{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:14:59Z","timestamp":1780514099679,"version":"3.54.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T00:00:00Z","timestamp":1495497600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s11060-017-2497-6","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T17:47:00Z","timestamp":1495561620000},"page":"139-143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Stereotactic radiosurgery for focal leptomeningeal disease in patients with brain metastases"],"prefix":"10.1007","volume":"134","author":[{"given":"Amparo","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadine","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua S.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Chachoua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Kondziolka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,23]]},"reference":[{"key":"2497_CR1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0733-8619(18)31006-5","volume":"3","author":"RA Patchell","year":"1985","unstructured":"Patchell RA, Posner JB (1985) Neurologic complications of systemic cancer. Neurol Clin 3:729\u2013750","journal-title":"Neurol Clin"},{"key":"2497_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0733-8619(02)00032-4","volume":"21","author":"S Kesari","year":"2003","unstructured":"Kesari S, Batchelor TT (2003) Leptomeningeal metastases. Neurol Clin 21:25\u201366","journal-title":"Neurol Clin"},{"key":"2497_CR3","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1053\/j.seminoncol.2009.05.006","volume":"36","author":"WR Shapiro","year":"2009","unstructured":"Shapiro WR, Johanson CE, Boogerd W (2009) Treatment modalities for leptomeningeal metastases. Semin Oncol 36:S46\u2013S54. doi: 10.1053\/j.seminoncol.2009.05.006","journal-title":"Semin Oncol"},{"key":"2497_CR4","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","volume":"49","author":"WR Wasserstrom","year":"1982","unstructured":"Wasserstrom WR, Glass JP, Posner JB (1982) Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49:759\u2013772","journal-title":"Cancer"},{"key":"2497_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2174\/157339411797642597","volume":"7","author":"T Leal","year":"2011","unstructured":"Leal T, Chang JE, Mehta M, Ian Robins H (2011) Leptomeningeal metastasis: challenges in diagnosis and treatment. Curr Cancer Ther Rev 7:319\u2013327. doi: 10.2174\/157339411797642597","journal-title":"Curr Cancer Ther Rev"},{"key":"2497_CR6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/PL00002398","volume":"177","author":"B Hermann","year":"2001","unstructured":"Hermann B, H\u00fcltenschmidt B, Sautter-Bihl ML (2001) Radiotherapy of the neuroaxis for palliative treatment of leptomeningeal carcinomatosis. Strahlenther Onkol 177:195\u2013199","journal-title":"Strahlenther Onkol"},{"key":"2497_CR7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.523","author":"MH Bertke","year":"2016","unstructured":"Bertke MH, Burton EC, Shaughnessy JN (2016) Stereotactic radiosurgery as part of multimodal treatment in a bulky leptomeningeal recurrence of breast cancer. Cureus. doi: 10.7759\/cureus.523","journal-title":"Cureus"},{"key":"2497_CR8","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.4103\/2152-7806.111304","volume":"4","author":"E Le Rhun","year":"2013","unstructured":"Le Rhun E, Taillibert S, Chamberlain MC (2013) Carcinomatous meningitis: leptomeningeal metastases in solid tumors. Surg Neurol Int 4:S265\u2013S288. doi: 10.4103\/2152-7806.111304","journal-title":"Surg Neurol Int"},{"key":"2497_CR9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1159\/000449405","volume":"9","author":"FS Fan","year":"2016","unstructured":"Fan FS (2016) Rapid response to high-dose, pulsatile erlotinib in afatinib-refractory leptomeningeal carcinomatosis from adenocarcinoma of the lung: a case report. Case Rep Oncol 9:537\u2013542. doi: 10.1159\/000449405","journal-title":"Case Rep Oncol"},{"key":"2497_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.lungcan.2016.07.008","volume":"99","author":"Y Sakata","year":"2016","unstructured":"Sakata Y, Kawamura K, Shingu N, Ichikado K (2016) Erlotinib plus bevacizumab as an effective treatment for leptomeningeal metastases from EGFR mutation-positive non-small cell lung cancer. Lung Cancer 99:120\u2013122. doi: 10.1016\/j.lungcan.2016.07.008","journal-title":"Lung Cancer"},{"key":"2497_CR11","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.2169\/internalmedicine.55.6102","volume":"55","author":"A Sekine","year":"2016","unstructured":"Sekine A, Kato T, Iwasawa T et al (2016) Promising effects of afatinib on leptomeningeal carcinomatosis derived from erlotinib-resistant lung adenocarcinoma. Intern Med 55:2457\u20132461. doi: 10.2169\/internalmedicine.55.6102","journal-title":"Intern Med"},{"key":"2497_CR12","unstructured":"ALEX study: a randomized, phase III study comparing alectinib with crizotinib in treatment-naive anaplastic lymphoma kinase-positive advanced non-small cell lung cancer participants. In: ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine (US). 2014-[cited 2015 Nov 2]. http:\/\/clinicaltrials.gov\/show\/NCT02075840 . NLM Identifier: NCT02075840)"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-017-2497-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2497-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2497-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T23:59:47Z","timestamp":1569369587000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-017-2497-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,23]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["2497"],"URL":"https:\/\/doi.org\/10.1007\/s11060-017-2497-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,23]]}}}